Can exercising at home before lung surgery be as good as going to a clinic?
NCT ID NCT06866717
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a prehabilitation program that combines home and center-based exercise works as well as a center-only program for people about to have lung cancer surgery. 38 adults with non-small cell lung cancer will be randomly assigned to either 15 sessions at the center or 3 center sessions plus 12 home sessions using a stationary bike and app. The main goal is to see if both groups improve their aerobic fitness equally before surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- prehabilitation program (exercise training with cycle ergometer, pulse oximeter, activity tracker, and tablet app)
- What this could lead to
- If it works, this could offer a more flexible, accessible way for lung cancer patients to improve their fitness before surgery, potentially leading to better recovery.
- What could go wrong
- This is a small, early-stage trial with only 38 participants, so results may not apply to everyone. Exercise carries risks like muscle soreness or injury, and the home-based approach may not match the center-based program's effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Association ADIR
RECRUITINGRouen, 76000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?